These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15194390)

  • 21. Islet of Langerhans transplantation for the treatment of type 1 diabetes.
    Bucher P; Mathe Z; Bosco D; Andres A; Bühler LH; Morel P; Berney T
    Swiss Surg; 2003; 9(5):242-6. PubMed ID: 14601328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycemic Control in Simultaneous Islet-Kidney Versus Pancreas-Kidney Transplantation in Type 1 Diabetes: A Prospective 13-Year Follow-up.
    Lehmann R; Graziano J; Brockmann J; Pfammatter T; Kron P; de Rougemont O; Mueller T; Zuellig RA; Spinas GA; Gerber PA
    Diabetes Care; 2015 May; 38(5):752-9. PubMed ID: 25665814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can daclizumab reduce acute rejection and improve long-term renal function in tacrolimus-based primary renal transplant recipients?
    Cheung CY; Liu YL; Wong KM; Chan HW; Chan YH; Wong HS; Chak WL; Choi KS; Chau KF; Shek CC; Li CS
    Nephrology (Carlton); 2008 Jun; 13(3):251-5. PubMed ID: 18221256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful simultaneous islet-kidney transplantation using a steroid-free immunosuppression: two-year follow-up.
    Lehmann R; Weber M; Berthold P; Züllig R; Pfammatter T; Moritz W; Mädler K; Donath M; Ambühl P; Demartines N; Clavien And PA; Andreia Spinas G
    Am J Transplant; 2004 Jul; 4(7):1117-23. PubMed ID: 15196070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two doses of daclizumab with delayed introduction of low-dose tacrolimus in elderly recipients of cadaveric renal transplants from donors >55 years of age.
    Osuna A; Gentil MA; Capdevila L; Cantarell C; Mazuecos A; Pereira P; Rodríguez-Algarra G; González-Molina M;
    Transplant Proc; 2005 Apr; 37(3):1438-40. PubMed ID: 15866630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience.
    Froud T; Ricordi C; Baidal DA; Hafiz MM; Ponte G; Cure P; Pileggi A; Poggioli R; Ichii H; Khan A; Ferreira JV; Pugliese A; Esquenazi VV; Kenyon NS; Alejandro R
    Am J Transplant; 2005 Aug; 5(8):2037-46. PubMed ID: 15996257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rabbit antithymocyte globulin induction and sirolimus monotherapy supports prolonged islet allograft function in a nonhuman primate islet transplantation model.
    Hirshberg B; Preston EH; Xu H; Tal MG; Neeman Z; Bunnell D; Soleimanpour S; Hale DA; Kirk AD; Harlan DM
    Transplantation; 2003 Jul; 76(1):55-60. PubMed ID: 12865786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating cytokines are associated with human islet graft function in type 1 diabetes.
    Pfleger C; Schloot NC; Brendel MD; Burkart V; Hogenkamp V; Bretzel RG; Jaeger C; Eckhard M
    Clin Immunol; 2011 Feb; 138(2):154-61. PubMed ID: 21094094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The start of an islet transplantation program in Japan.
    Saito T; Ise K; Sato Y; Gotoh M; Matsumoto S; Kenmochi T; Kuroda Y; Yasunami Y; Inoue K; Teraoka S
    Transplant Proc; 2005 Oct; 37(8):3424-6. PubMed ID: 16298616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sirolimus-based immunosuppression in kidney transplantation for type 2 diabetic nephropathy.
    Veroux M; Corona D; Giuffrida G; Gagliano M; Vizcarra D; Tallarita T; Zerbo D; Giaquinta A; Sorbello M; Macarone M; Veroux P
    Urol Int; 2010; 84(3):301-4. PubMed ID: 20389159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rejection after simultaneous pancreas-kidney transplantation.
    Arbogast H; Malaise J; Illner WD; Tarabichi A; Dieterle C; Landgraf R; Land W;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii11-7, ii62. PubMed ID: 15814544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
    Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spectrum of surgical complications after simultaneous pancreas-kidney transplantation in a prospectively randomized study of two immunosuppressive protocols.
    Steurer W; Malaise J; Mark W; Koenigsrainer A; Margreiter R;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii54-62. PubMed ID: 15814551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pancreas islet transplantation in patients with type 1 diabetes mellitus after kidney transplantation.
    Gonzalez Molina M; Alonso A; Briones R; Fernandez N; Caballero A; Miranda JM; Navarro A; Castro MJ; Burgos D; Cabello M; Sola E; Escaño A; Muñoz J
    Transplant Proc; 2005 Apr; 37(3):1443-5. PubMed ID: 15866632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intraperitoneal insulin infusion versus islet transplantation: comparative study in patients with type 1 diabetes.
    Vantyghem MC; Marcelli-Tourvieille S; Fermon C; Duhamel A; Raverdy V; Arnalsteen L; Kerr-Conte J; Noel C; Fontaine P; Pattou F
    Transplantation; 2009 Jan; 87(1):66-71. PubMed ID: 19136893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated portal vein drug levels of sirolimus and tacrolimus in islet transplant recipients: local immunosuppression or islet toxicity?
    Desai NM; Goss JA; Deng S; Wolf BA; Markmann E; Palanjian M; Shock AP; Feliciano S; Brunicardi FC; Barker CF; Naji A; Markmann JF
    Transplantation; 2003 Dec; 76(11):1623-5. PubMed ID: 14702535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolutionary experience with immunosuppression in pediatric intestinal transplantation.
    Bond GJ; Mazariegos GV; Sindhi R; Abu-Elmagd KM; Reyes J
    J Pediatr Surg; 2005 Jan; 40(1):274-9; discussion 279-80. PubMed ID: 15868597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simultaneous pancreas-kidney transplantation: five-year results from a single center.
    Martins L; Pedroso S; Henriques AC; Dias L; Sarmento AM; Seca R; Oliveira F; Dores J; Lhamas A; Coelho T; Ribeiro A; Esteves S; Pereira R; Almeida R; Amil M; Cabrita A; Teixeira M
    Transplant Proc; 2006; 38(6):1929-32. PubMed ID: 16908326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.